Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Drug Therapy for Arrhythmias in ATS and MEPPC
NCT06205550Phase 2Not yet recruiting
- Sponsor
- University of Amsterdam
- Start
- Mar 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of flecainide in Andersen-Tawil syndrome (ATS), Multifocal Ectopic Purkinje-related Premature Contractions (MEPPC), sponsored by University of Amsterdam. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
flecainide
03
Conditions
Andersen-Tawil syndrome (ATS)Multifocal Ectopic Purkinje-related Premature Contractions (MEPPC)
Beyond the preview
Go deeper on NCT06205550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06205550.